MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1–3 Prior Lines of Therapy (LOT)
Jens Hillengass, Adam D. Cohen, Michel Delforge, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Marc Steffen Raab, Christof Scheid, Jordan M. Schecter, Kevin C. de Braganca, Helen Varsos, Tzu min Yeh, Pankaj Mistry, Tito Roccia, Christina Corsale, Muhammad Akram, Lida Pacaud, Tonia Nesheiwat, Mounzer Agha, Yael C. Cohen
Research output: Contribution to journal › Article › peer-review
6Scopus
citations
Fingerprint
Dive into the research topics of 'MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1–3 Prior Lines of Therapy (LOT)'. Together they form a unique fingerprint.